News Agency
The Times

Regor Releases Phase 2a Topline Results for RGT-075, an Oral Once-daily Small Molecule GLP-1R Agonist, and Begins Phase 2b Study in the US for the Treatment of Obesity

  • Written by PR Newswire
  • Regor announced its 12-week single-dose Phase 2a trial results for RGT-075, a once-daily oral GLP-1RA, reporting 5% placebo-adjusted weight-loss with no plateau
  • No treatment-related severe adverse events (AEs), with only 4% discontinuation rate due to AEs, same as placebo
  • Enrollment opening for its COMO-1 Phase 2b dose-finding study to read out Q4...

Read more: Regor Releases Phase 2a Topline Results for RGT-075, an Oral Once-daily Small Molecule GLP-1R...

How to Choose a Local SEO Agency That Can Generate Real Enquiries, Not Just Rankings

A local SEO proposal may promise improved Google Maps visibility, extra keywords, and monthly reports. Those can be useful, but they do not automatically mean the business will receive more calls from suitable customers. Before committing to a contract, owners... Read more

Writers Wanted



NewsServices.com

Content & Technology Connecting Global Audiences

More Information - Less Opinion